Northwestern Medicine and Siemens Healthineers have launched a strategic collaboration aimed at advancing cancer diagnostics and treatment across the greater Chicago area.

The multiyear partnership will focus on integrating imaging, theranostics, interventional radiology, and radiation oncology to enhance precision care delivery.

According to Chicago-based Northwestern Medicine, the agreement marks the beginning of a phased collaboration that will combine clinical expertise with advanced imaging and software technologies from Siemens Healthineers, which is headquartered in Malvern, Pennsylvania.
“This alliance represents our unwavering commitment to innovation in imaging and cancer care,” said Dr. James Carr, chair of the department of radiology at Northwestern Medicine and professor at Northwestern University Feinberg School of Medicine. “By integrating Siemens Healthineers’ advanced technologies with Northwestern Medicine’s clinical expertise, we can create a future where patients benefit from faster diagnoses, more personalized treatments, and transformative outcomes across the continuum of care."

One of the primary goals of the collaboration is to establish a global center of excellence in theranostics, a growing field that uses radiopharmaceuticals to both detect and treat cancer. Other focus areas include reworking oncology care pathways to improve efficiency and patient experience, expanding interventional MR and minimally invasive procedures, and using artificial intelligence to optimize radiation oncology workflows.

“With more than 20 years of research collaboration, we have in Northwestern Medicine an innovative collaborator dedicated to making important strides in cancer care, both improving care quality and offering access to care closer to patients’ homes,” said John Kowal, president and head of the Americas at Siemens Healthineers.

U.S. Healthcare Homepage